Jiang Jennifer, Keniya Mikhail V, Puri Anusha, Zhan Xueying, Cheng Jeff, Wang Huan, Lin Gigi, Lee Yun-Kyung, Jaber Nora, Hassoun Yasmine, Shor Erika, Shi Zheng, Lee Sang-Hyuk, Xu Min, Perlin David S, Dai Wei
bioRxiv. 2024 May 30:2024.05.29.596243. doi: 10.1101/2024.05.29.596243.
Fungal plasma membrane proteins represent key therapeutic targets for antifungal agents, yet their structure and spatial distribution in the native context remain poorly characterized. Herein, we employ an integrative multimodal approach to elucidate the structural and functional organization of plasma membrane protein complexes in , focusing on prominent and essential membrane proteins, the polysaccharide synthase β-(1,3)-glucan synthase (GS) and the proton pump Pma1. Cryo-electron tomography (cryo-ET) and live cell imaging reveal that GS and Pma1 are heterogeneously distributed into distinct plasma membrane microdomains. Treatment with caspofungin, an echinocandin antifungal that targets GS, alters the plasma membrane and disrupts the native distribution of GS and Pma1. Based on these findings, we propose a model for echinocandin action that considers how drug interactions with the plasma membrane environment lead to inhibition of GS. Our work underscores the importance of interrogating the structural and dynamic characteristics of fungal plasma membrane proteins to understand function and facilitate precisely targeted development of novel antifungal therapies.
真菌质膜蛋白是抗真菌药物的关键治疗靶点,但其在天然环境中的结构和空间分布仍知之甚少。在此,我们采用综合多模态方法来阐明酿酒酵母质膜蛋白复合物的结构和功能组织,重点关注突出且必需的膜蛋白、多糖合酶β-(1,3)-葡聚糖合酶(GS)和质子泵Pma1。冷冻电子断层扫描(cryo-ET)和活细胞成像显示,GS和Pma1异质分布于不同的质膜微区。用卡泊芬净治疗,一种靶向GS的棘白菌素类抗真菌药物,会改变质膜并破坏GS和Pma1的天然分布。基于这些发现,我们提出了一种棘白菌素作用模型,该模型考虑了药物与质膜环境的相互作用如何导致GS的抑制。我们的工作强调了研究真菌质膜蛋白的结构和动态特征对于理解功能以及促进新型抗真菌疗法精准靶向开发的重要性。